Furthermore, patients with heterozygous mutations in CTLA4 also often exhibit B-cell defects and hypogammaglobulinemia, and the reason for this remains unclear [4, 5] (Supplementary Fig. 1A and Supplementary Table 1). The gene discussed is CTLA4; the disease is agammaglobulinemia.